Literature DB >> 195075

Establishment of an Epstein-Barr virus-determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia.

S Hiraki, I Miyoshi, H Masuji, I Kubonishi, Y Matsuda.   

Abstract

A human B-cell line designated as BALL-1 was established from the peripheral blood of a patient with acute lymphoblastic leukemia (ALL). Neither Epstein-Barr virus (EBV) particles nor EBV-determined nuclear antigen (EBNA) was detectable. The morphologic and growth characteristics were clearly distinct from those of numerous EBV-positive lymphoblastoid cell lines previously reported. BALL-1 cells probably originated from the donor's leukemia cells as judged from their cytogenetic, morphologic, and surface features. The BALL-1 line was the first EBNA-negative B-cell line established from ALL.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 195075     DOI: 10.1093/jnci/59.1.93

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Lymphoid cell line identification and the detection of cross contamination.

Authors:  B R Conner; S Ferrone; M A Pellegrino; R Glaser
Journal:  In Vitro       Date:  1980-05

2.  Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment.

Authors:  M Mackett; M J Conway; J R Arrand; R S Haddad; L M Hutt-Fletcher
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines.

Authors:  A Harris; B D Young; B E Griffin
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

4.  The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein.

Authors:  W Y Langdon; C D Hyland; R J Grumont; H C Morse
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.

Authors:  David Caudell; David P Harper; Rachel L Novak; Rachel M Pierce; Christopher Slape; Linda Wolff; Peter D Aplan
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

6.  Identification of an Epstein-Barr virus-coded thymidine kinase.

Authors:  E Littler; J Zeuthen; A A McBride; E Trøst Sørensen; K L Powell; J E Walsh-Arrand; J R Arrand
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

7.  Cytoplasmic RNA from normal and malignant human cells shows homology to the DNAs of Epstein-Barr virus and human adenoviruses.

Authors:  J R Arrand; J E Walsh-Arrand; L Rymo
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

8.  Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.

Authors:  C E Andoniou; C B Thien; W Y Langdon
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.